129 related articles for article (PubMed ID: 1832602)
1. Effects of dobutamine and salbutamol on haemodynamics and atrial natriuretic factor in patients with severe congestive heart failure.
Keller N; Sykulski R; Larsen J
Clin Physiol; 1991 May; 11(3):199-210. PubMed ID: 1832602
[TBL] [Abstract][Full Text] [Related]
2. Changes in atrial natriuretic factor during preload reduction with nitroglycerin in patients with congestive heart failure.
Keller N; Sykulski R; Thamsborg G; Storm T; Larsen J
Clin Physiol; 1988 Feb; 8(1):57-64. PubMed ID: 2964972
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms involved in the response to prolonged infusion of atrial natriuretic factor in patients with chronic heart failure.
Münzel T; Drexler H; Holtz J; Kurtz S; Just H
Circulation; 1991 Jan; 83(1):191-201. PubMed ID: 1845857
[TBL] [Abstract][Full Text] [Related]
4. Interaction of intravenous atrial natriuretic factor with furosemide in patients with heart failure.
Connelly TP; Francis GS; Williams KJ; Beltran AM; Cohn JN
Am Heart J; 1994 Feb; 127(2):392-9. PubMed ID: 8296708
[TBL] [Abstract][Full Text] [Related]
5. Low-dose infusion of atrial natriuretic factor in mild essential hypertension.
Tonolo G; Richards AM; Manunta P; Troffa C; Pazzola A; Madeddu P; Towrie A; Fraser R; Glorioso N
Circulation; 1989 Oct; 80(4):893-902. PubMed ID: 2529059
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic response to intracoronary infusion of atrial natriuretic factor in patients with normal or altered left ventricular function.
Dubois-Rande JL; Adnot S; Benvenuti C; Merlet P; Hittinger L; Sediame S; Chabrier E; Braquet P; Castaigne A
J Cardiovasc Pharmacol; 1991 Apr; 17(4):608-14. PubMed ID: 1711628
[TBL] [Abstract][Full Text] [Related]
7. Atrial natriuretic factor during exercise in patients with congestive heart failure.
Keller N; Larsen J; Sykulski R; Storm T; Thamsborg G
Acta Endocrinol (Copenh); 1988 Jun; 118(2):168-72. PubMed ID: 2968748
[TBL] [Abstract][Full Text] [Related]
8. Effects of prostaglandin E1, dobutamine and placebo on hemodynamic, renal and neurohumoral variables in patients with advanced heart failure.
Wimmer A; Stanek B; Kubecova L; Vitovec J; Spinar J; Yilmaz N; Kos T; Hartter E; Frey B; Pacher R
Jpn Heart J; 1999 May; 40(3):321-34. PubMed ID: 10506854
[TBL] [Abstract][Full Text] [Related]
9. Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure.
Mager G; Klocke RK; Kux A; Höpp HW; Hilger HH
Am Heart J; 1991 Jun; 121(6 Pt 2):1974-83. PubMed ID: 1852090
[TBL] [Abstract][Full Text] [Related]
10. Different hemodynamic effects of atrial natriuretic factor and nitroglycerin in rats with congestive heart failure.
Chien YW; Trippodo NC; Frohlich ED
Am J Physiol; 1989 Dec; 257(6 Pt 2):R1481-7. PubMed ID: 2532483
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic and neurohumoral responses to intravenous nicorandil in congestive heart failure in humans.
Giles TD; Pina IL; Quiroz AC; Roffidal L; Zaleski R; Porter RS; Karalis DG; Mohrland JS; Wolf DL; Hearron AE
J Cardiovasc Pharmacol; 1992 Oct; 20(4):572-8. PubMed ID: 1280713
[TBL] [Abstract][Full Text] [Related]
12. Comparative hemodynamic effects of intravenous dobutamine and dibutyryl cyclic AMP, a new inotropic agent, in severe congestive heart failure.
Miyagi Y; Sasayama S; Nakajima H; Fujita M; Asanoi H
J Cardiovasc Pharmacol; 1990 Jan; 15(1):138-43. PubMed ID: 1688971
[TBL] [Abstract][Full Text] [Related]
13. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.
Cody RJ; Atlas SA; Laragh JH; Kubo SH; Covit AB; Ryman KS; Shaknovich A; Pondolfino K; Clark M; Camargo MJ
J Clin Invest; 1986 Nov; 78(5):1362-74. PubMed ID: 2945832
[TBL] [Abstract][Full Text] [Related]
14. Effects of atrial natriuretic factor on coronary hemodynamics and myocardial energetics in patients with heart failure.
Herrmann HC; Palacios IF; Dec GW; Scheer JM; Fifer MA
Am Heart J; 1988 Jun; 115(6):1232-8. PubMed ID: 2967626
[TBL] [Abstract][Full Text] [Related]
15. Dobutamine and nitroprusside infusion in patients with severe congestive heart failure: hemodynamic improvement by discordant effects on mitral regurgitation, left atrial function, and ventricular function.
Capomolla S; Pozzoli M; Opasich C; Febo O; Riccardi G; Salvucci F; Maestri R; Sisti M; Cobelli F; Tavazzi L
Am Heart J; 1997 Dec; 134(6):1089-98. PubMed ID: 9424070
[TBL] [Abstract][Full Text] [Related]
16. Cardiac secretion of atrial natriuretic factor with exercise in chronic congestive heart failure patients.
Cody RJ; Kubo SH; Laragh JH; Atlas SA
J Appl Physiol (1985); 1992 Oct; 73(4):1637-43. PubMed ID: 1360003
[TBL] [Abstract][Full Text] [Related]
17. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
La Vecchia L; Bottero M; Centofante P; Bedogni F; Ometto R; Cera A; Fortunato A
G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic comparison of intravenous amrinone and dobutamine in patients with chronic congestive heart failure.
Klein NA; Siskind SJ; Frishman WH; Sonnenblick EH; LeJemtel TH
Am J Cardiol; 1981 Jul; 48(1):170-5. PubMed ID: 7246440
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic effects of a new inotropic agent, piroximone (MDL 19205), in patients with chronic heart failure.
Petein M; Levine TB; Cohn JN
J Am Coll Cardiol; 1984 Aug; 4(2):364-71. PubMed ID: 6736478
[TBL] [Abstract][Full Text] [Related]
20. Neurohormonal inhibition and hemodynamic unloading during prolonged inhibition of ANF degradation in patients with severe chronic heart failure.
Münzel T; Kurz S; Holtz J; Busse R; Steinhauer H; Just H; Drexler H
Circulation; 1992 Oct; 86(4):1089-98. PubMed ID: 1394917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
